Samsung Biologics삼성바이오로직스

Credit rating

• AAKorea Investors Service · corporate bonds · Rated Jun 30, 2026
• AANICE Investors Service · corporate bonds · Rated Jun 24, 2026
• AAKorea Ratings · corporate bonds · Rated Apr 20, 2026

Bonds outstanding

₩600B in 1 bond

1. ≤6 months—
2. 6–12 months₩600B
3. 1–2 years—
4. 2–3 years—
5. 3–5 years—
6. Over 5 years—

We read bond filings from Oct 25, 2021; older bonds may be missing.

Due soon vs cash

Due in 6 months

₩0

Due in 12 months

₩600B

Cash and equivalents

₩289B

Cash from the 2026 H1 statements

How it has moved with rates and the won

Average move of the shares on days the factor changed, over the last year. Describes the past, not a forecast.

• −0.95% per 10 bp rise in KTB 3ysome link · correlation -0.17 over 253 days
• −0.4% per 1% rise in USD/KRWweak link · correlation -0.09 over 253 days